Header Logo

Connection

RICHARD KELLERMAYER to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications RICHARD KELLERMAYER has written about Drug Administration Schedule.
RICHARD KELLERMAYER
Connection Strength
0.053
Drug Administration Schedule
  1. Evaluating the impact of infliximab use on surgical outcomes in pediatric Crohn's disease. J Pediatr Surg. 2016 May; 51(5):786-9.
    View in: PubMed
    Score: 0.029
  2. Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.